{
  "page": 2,
  "value": [
    {
      "path": "_news/2020-05-06-these-23-companies-are-working-on-coronavirus-treatments-or-vaccines-heres-where-things-stand.md",
      "title": "These 23 companies are working on coronavirus treatments or vaccines — here’s where things stand",
      "excerpt": "A mix of legacy drugmakers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the",
      "heat": 107,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.marketwatch.com/story/these-nine-companies-are-working-on-coronavirus-treatments-or-vaccines-heres-where-things-stand-2020-03-06",
      "ampWebUrl": "https://www.marketwatch.com/amp/story/guid/1E86A2BC-5F10-11EA-9EB1-848872F13637",
      "cdnAmpWebUrl": "https://www-marketwatch-com.cdn.ampproject.org/c/s/www.marketwatch.com/amp/story/guid/1E86A2BC-5F10-11EA-9EB1-848872F13637",
      "publishedDateTime": "2020-05-06T10:50:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "MarketWatch",
        "domain": "marketwatch.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/marketwatch.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s.marketwatch.com/public/resources/images/MW-IB594_COVIDl_ZH_20200305152109.jpg",
          "width": 890,
          "height": 501,
          "title": "These 23 companies are working on coronavirus treatments or vaccines — here’s where things stand",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-06-remdesivir-helps-coronavirus-patients-but-at-what-cost.md",
      "title": "Remdesivir helps coronavirus patients — but at what cost?",
      "excerpt": "Gilead has rocketed into the public consciousness with one of the most promising coronavirus treatments, but the company’s history of sky high drug pricing is drawing increasing scrutiny from Congress about how much it will charge for remdesivir and who will get access.",
      "heat": 115,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.politico.com/news/2020/05/06/remdesivir-helps-coronavirus-patients-but-at-what-cost-240230",
      "ampWebUrl": "https://www.politico.com/amp/news/2020/05/06/remdesivir-helps-coronavirus-patients-but-at-what-cost-240230",
      "cdnAmpWebUrl": "https://www-politico-com.cdn.ampproject.org/c/s/www.politico.com/amp/news/2020/05/06/remdesivir-helps-coronavirus-patients-but-at-what-cost-240230",
      "publishedDateTime": "2020-05-06T10:48:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Politico",
        "domain": "politico.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static.politico.com/cb/5a/2c1a7a5c4545bcecf70f3ebd5396/gettyimages-1221879711.jpg",
          "width": 1160,
          "height": 773,
          "title": "Remdesivir helps coronavirus patients — but at what cost?",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Political Impact"
      ]
    },
    {
      "path": "_news/2020-05-06-will-gilead-price-its-coronavirus-drug-for-public-good-or-company-profit.md",
      "title": "Will Gilead price its coronavirus drug for public good or company profit?",
      "excerpt": "Gilead Sciences Inc faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus.",
      "heat": 104,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-health-coronavirus-gilead-pricing-idUSKBN22I2NM",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKBN22I2NM",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN22I2NM",
      "publishedDateTime": "2020-05-06T10:15:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s1.reutersmedia.net/resources/r/?m=02&d=20200506&t=2&i=1517696900&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG451Q2",
          "width": 752,
          "height": 545,
          "title": "Will Gilead price its coronavirus drug for public good or company profit?",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-06-the-conference-call-to-cure-covid-19.md",
      "title": "The Conference Call to Cure Covid-19",
      "excerpt": "Research leaders inside pharmaceutical companies are cooperating, but they need a public spokesman.",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.wsj.com/articles/the-conference-call-to-cure-covid-19-11588784648",
      "ampWebUrl": "https://www.wsj.com/amp/articles/the-conference-call-to-cure-covid-19-11588784648",
      "cdnAmpWebUrl": "https://www-wsj-com.cdn.ampproject.org/c/s/www.wsj.com/amp/articles/the-conference-call-to-cure-covid-19-11588784648",
      "publishedDateTime": "2020-05-06T10:13:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Wall Street Journal",
        "domain": "wsj.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/wsj.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://images.wsj.net/im-184181/social",
          "width": 1279,
          "height": 640,
          "title": "The Conference Call to Cure Covid-19",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-06-couple-who-recovered-from-covid-19-donate-plasma-for-coronavirus-research.md",
      "title": "Couple who recovered from COVID-19 donate plasma for coronavirus research",
      "excerpt": "In those who have recovered from the disease, their plasma contains antibodies, developed by the immune system, that helped them fight the infection. While there is still much to know about the treatment of COVID-19,",
      "heat": 104,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.inquirer.com/life/covid-19-donating-plasma-thomas-jefferson-university-hospital-richard-maria-wells-20200506.html",
      "ampWebUrl": "https://www.inquirer.com/life/covid-19-donating-plasma-thomas-jefferson-university-hospital-richard-maria-wells-20200506.html?outputType=amp",
      "cdnAmpWebUrl": "https://www-inquirer-com.cdn.ampproject.org/c/s/www.inquirer.com/life/covid-19-donating-plasma-thomas-jefferson-university-hospital-richard-maria-wells-20200506.html?outputType=amp",
      "publishedDateTime": "2020-05-06T09:07:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Philadelphia Inquirer",
        "domain": "inquirer.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.inquirer.com/resizer/rIRkQGogNc6Nt4-G8fSDlfm4zg0=/1200x0/center/middle/www.inquirer.com/resizer/8YbwARdhLrVEXnDj17zSeUzwBPQ=/1200x0/center/middle/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/LDSCEVB7SNDEJB3Y624PNOQK3I.jpg",
          "width": 1200,
          "height": 900,
          "title": "Couple who recovered from COVID-19 donate plasma for coronavirus research",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-06-the-simpsons-came-eerily-close-to-predicting-the-coronavirus-and-murder-hornets.md",
      "title": "'The Simpsons' came eerily close to predicting the coronavirus and murder hornets",
      "excerpt": "Just add coronavirus and murder hornets to the long list of things The Simpsons predicted. OK, so like most of the famous Simpsons predictions, it isn't exactly a prediction of 2020, but it is pretty damn close.",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://mashable.com/article/simpsons-predict-coronavirus-murder-hornets/",
      "ampWebUrl": "https://mashable.com/article/simpsons-predict-coronavirus-murder-hornets.amp",
      "cdnAmpWebUrl": "https://mashable-com.cdn.ampproject.org/c/s/mashable.com/article/simpsons-predict-coronavirus-murder-hornets.amp",
      "publishedDateTime": "2020-05-06T08:44:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Mashable",
        "domain": "mashable.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://mondrian.mashable.com/2020%252F05%252F06%252F1f%252F8a3e61a7fc414bb28384e544f007e8ff.01179.png%252F1200x630.png?signature=fw3GFS-G-iPdENQvnuI1ByfZBJU=",
          "width": 1200,
          "height": 630,
          "title": "'The Simpsons' came eerily close to predicting the coronavirus and murder hornets",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Coronavirus in Asia"
      ]
    },
    {
      "path": "_news/2020-05-06-israel-reports-a-breakthrough-coronavirus-antibody-treatment.md",
      "title": "Israel Reports a \"Breakthrough\" Coronavirus Antibody Treatment",
      "excerpt": "While a vaccine for COVID-19 could be a year or two away at the very least, many market participants have been pinning their hopes on an effective treatment in the meantime. In a best-case scenario, such a treatment could mitigate the worst outcomes in at-risk patients and potentially cure the disease in a majority of patients.",
      "heat": 130,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.fool.com/investing/2020/05/06/israel-reports-a-breakthrough-coronavirus-antibody.aspx",
      "ampWebUrl": "https://www.fool.com/amp/investing/2020/05/06/israel-reports-a-breakthrough-coronavirus-antibody.aspx",
      "cdnAmpWebUrl": "https://www-fool-com.cdn.ampproject.org/c/s/www.fool.com/amp/investing/2020/05/06/israel-reports-a-breakthrough-coronavirus-antibody.aspx",
      "publishedDateTime": "2020-05-06T04:59:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Motley Fool",
        "domain": "fool.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/fool.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://g.foolcdn.com/editorial/images/497755/istock_000016851885_large_large.jpg",
          "width": 580,
          "height": 378,
          "title": "Israel Reports a \"Breakthrough\" Coronavirus Antibody Treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Travel Impact"
      ]
    },
    {
      "path": "_news/2020-05-06-the-urgent-quest-for-a-coronavirus-treatment-involves-door-to-door-blood-collection-and-a-llama-named-winter.md",
      "title": "The urgent quest for a coronavirus treatment involves door-to-door blood collection and a llama named Winter",
      "excerpt": "Companies and researchers are using llamas, door-to-door phlebotomists and genetically engineered mice in the hunt for coronavirus treatments inspired by the immune system.",
      "heat": 111,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.washingtonpost.com/science/2020/05/06/urgent-quest-coronavirus-treatment-involves-door-to-door-blood-collection-llama-named-winter/",
      "ampWebUrl": "https://www.washingtonpost.com/science/2020/05/06/urgent-quest-coronavirus-treatment-involves-door-to-door-blood-collection-llama-named-winter/?outputType=amp",
      "cdnAmpWebUrl": "https://www-washingtonpost-com.cdn.ampproject.org/c/s/www.washingtonpost.com/science/2020/05/06/urgent-quest-coronavirus-treatment-involves-door-to-door-blood-collection-llama-named-winter/?outputType=amp",
      "publishedDateTime": "2020-05-06T04:05:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Washington Post",
        "domain": "washingtonpost.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/washingtonpost.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.washingtonpost.com/resizer/HSeQboW-t0HurJtoiXh-EhNR6C0=/1440x0/smart/arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/KEAV4MDPL5BJTNSOW2RA55KZDA.jpg",
          "width": 1440,
          "height": 960,
          "title": "The urgent quest for a coronavirus treatment involves door-to-door blood collection and a llama named Winter",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-06-who-can-make-gileads-coronavirus-drug-licence-free.md",
      "title": "Who can make Gilead's coronavirus drug, licence free?",
      "excerpt": "Gilead Sciences Inc is in talks with chemical and drug makers to produce its experimental drug remdesivir, a potential coronavirus treatment, for Europe, Asia and the developing world, the firm has said.",
      "heat": 115,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-health-coronavirus-gilead-sciences-ex-idUSKBN22I1GP",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKBN22I1GP",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN22I1GP",
      "publishedDateTime": "2020-05-06T03:57:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s2.reutersmedia.net/resources/r/?m=02&d=20200506&t=2&i=1517641619&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG450VC",
          "width": 817,
          "height": 545,
          "title": "Who can make Gilead's coronavirus drug, licence free?",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-06-is-this-coronavirus-drug-authorization-really-good-news-for-gilead.md",
      "title": "Is This Coronavirus Drug Authorization Really Good News for Gilead?",
      "excerpt": "Gilead may spend as much as $1 billion this year on remdesivir -- but it still hasn’t said how much revenue the drug may generate.",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.fool.com/investing/2020/05/06/is-this-coronavirus-drug-authorization-really-good.aspx",
      "ampWebUrl": "https://www.fool.com/amp/investing/2020/05/06/is-this-coronavirus-drug-authorization-really-good.aspx",
      "cdnAmpWebUrl": "https://www-fool-com.cdn.ampproject.org/c/s/www.fool.com/amp/investing/2020/05/06/is-this-coronavirus-drug-authorization-really-good.aspx",
      "publishedDateTime": "2020-05-06T03:20:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Motley Fool",
        "domain": "fool.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/fool.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://g.foolcdn.com/editorial/images/497755/istock_000016851885_large_large.jpg",
          "width": 580,
          "height": 378,
          "title": "Is This Coronavirus Drug Authorization Really Good News for Gilead?",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-06-australian-healing-church-defends-bleach-sales-after-us-coronavirus-cure-claims.md",
      "title": "Australian 'healing church' defends bleach sales after US coronavirus cure claims",
      "excerpt": "Group claims it should be allowed to promote its Miracle Mineral Solution on freedom of religion grounds",
      "heat": 100,
      "tags": [
        "Australia",
        "AU"
      ],
      "type": "article",
      "webUrl": "https://www.theguardian.com/australia-news/2020/may/06/australian-healing-church-defends-bleach-sales-after-us-coronavirus-cure-claims",
      "ampWebUrl": "https://amp.theguardian.com/australia-news/2020/may/06/australian-healing-church-defends-bleach-sales-after-us-coronavirus-cure-claims",
      "cdnAmpWebUrl": "https://amp-theguardian-com.cdn.ampproject.org/c/s/amp.theguardian.com/australia-news/2020/may/06/australian-healing-church-defends-bleach-sales-after-us-coronavirus-cure-claims",
      "publishedDateTime": "2020-05-05T22:21:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Guardian",
        "domain": "theguardian.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/theguardian.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://i.guim.co.uk/img/media/d438e6e875763d6cb87dcea0e421c0e109e28a92/0_0_1398_643/master/1398.jpg?width=300&quality=45&auto=format&fit=max&dpr=2&s=08a2d907a588a8c376878899d574c19b",
          "width": 600,
          "height": 276,
          "title": "Australian 'healing church' defends bleach sales after US coronavirus cure claims",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-06-how-a-brewery-is-combating-covid-19-and-helping-a-nearby-hospital-test-patients.md",
      "title": "How a brewery is combating COVID-19 and helping a nearby hospital test patients",
      "excerpt": "Sierra Nevada Brewing Co. is making the transport medium needed to process COVID-19 tests for northern California neighbor Enloe Medical Center.",
      "heat": 116,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.usatoday.com/story/money/business/2020/05/05/coronavirus-test-liquid-made-hospital-sierra-nevada-brewing-co/3075783001/",
      "ampWebUrl": "https://amp.usatoday.com/amp/3075783001",
      "cdnAmpWebUrl": "https://amp-usatoday-com.cdn.ampproject.org/c/s/amp.usatoday.com/amp/3075783001",
      "publishedDateTime": "2020-05-05T21:39:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "USA Today",
        "domain": "usatoday.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/usatoday.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.gannett-cdn.com/presto/2020/05/04/USAT/617d99b3-5bce-4352-b87f-84ea4bc76800-SN_Quality_Lab_042920-9.jpg?auto=webp&crop=2549,1434,x0,y66&format=pjpg&width=1200",
          "width": 1200,
          "height": 675,
          "title": "How a brewery is combating COVID-19 and helping a nearby hospital test patients",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-06-exclusive-sanofi-to-enroll-thousands-for-its-coronavirus-vaccine-trials.md",
      "title": "EXCLUSIVE-Sanofi to enroll thousands for its coronavirus vaccine trials",
      "excerpt": "Sanofi is working on two vaccine projects to prevent COVID-19 and said it is exploring several manufacturing options ... similar to experimental vaccines being developed by Pfizer Inc in partnership with BioNTech SE and another Moderna Inc is developing in partnership with the U.S. government. The mRNA technology instructs cells in the body ...",
      "heat": 125,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/health-coronavirus-sanofi/exclusive-sanofi-to-enroll-thousands-for-its-coronavirus-vaccine-trials-idUSL1N2CN2II",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSL1N2CN2II",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSL1N2CN2II",
      "publishedDateTime": "2020-05-05T17:02:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s4.reutersmedia.net/resources_v3/images/rcom-default.png",
          "width": 1200,
          "height": 630,
          "title": "EXCLUSIVE-Sanofi to enroll thousands for its coronavirus vaccine trials",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-cat-coronavirus-drug-shows-promise-for-treatment-of-covid-19.md",
      "title": "Cat coronavirus drug shows promise for treatment of COVID-19",
      "excerpt": "They are strong drug candidates for the treatment of human coronavirus infections because they have already been successful in animals (cats),” writes the team. “The work here lays the framework for their use in human trials for the treatment of COVID-19.",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.news-medical.net/news/20200505/Cat-coronavirus-drug-shows-promise-for-treatment-of-COVID-19.aspx",
      "ampWebUrl": "https://www.news-medical.net/amp/news/20200505/Cat-coronavirus-drug-shows-promise-for-treatment-of-COVID-19.aspx",
      "cdnAmpWebUrl": "https://www-news--medical-net.cdn.ampproject.org/c/s/www.news-medical.net/amp/news/20200505/Cat-coronavirus-drug-shows-promise-for-treatment-of-COVID-19.aspx",
      "publishedDateTime": "2020-05-05T15:04:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "News Medical",
        "domain": "news-medical.net",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.news-medical.net/image.axd?picture=2020%2f5%2f%40%40%4040db1_k_9da52b4a24c9403b8ba34c726d9741ed-620x480.jpg",
          "width": 620,
          "height": 480,
          "title": "Cat coronavirus drug shows promise for treatment of COVID-19",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-garmin-how-wearable-data-can-aid-covid-19-treatment-research.md",
      "title": "Garmin: How wearable data can aid COVID-19 treatment, research",
      "excerpt": "ZDNet's Larry Dignan spoke with Phil McClendon, lead product manager for Garmin consumer wearables, and Sean McNamara, who manages sales and marketing for the Garmin Health, about how wearable data can help researchers battle COVID-19.",
      "heat": 115,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.zdnet.com/video/garmin-how-wearable-data-can-aid-covid-19-treatment-research/",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-05-05T12:43:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "ZDNet",
        "domain": "zdnet.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/zdnet.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://zdnet2.cbsistatic.com/hub/i/r/2020/05/05/af546f02-b59b-4d56-9192-d523115e675f/thumbnail/770x578/302f4c32b71f40300cc8b40a57d6c5d1/20200504-garmin-larry.jpg",
          "width": 770,
          "height": 578,
          "title": "Garmin: How wearable data can aid COVID-19 treatment, research",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-regeneron-says-its-covid-19-combo-treatment-could-be-ready-for-people-this-fall.md",
      "title": "Regeneron Says Its COVID-19 Combo Treatment Could Be Ready for People This Fall",
      "excerpt": "During Regeneron 's ( NASDAQ:REGN) earnings call on Tuesday, Chief Scientific Officer George Yancopoulos told analysts that the company planned to start human trials of REGN-COV2, the company's experimental COVID-19 treatment,",
      "heat": 116,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.fool.com/investing/2020/05/05/regeneron-says-its-covid-19-combo-treatment-could.aspx",
      "ampWebUrl": "https://www.fool.com/amp/investing/2020/05/05/regeneron-says-its-covid-19-combo-treatment-could.aspx",
      "cdnAmpWebUrl": "https://www-fool-com.cdn.ampproject.org/c/s/www.fool.com/amp/investing/2020/05/05/regeneron-says-its-covid-19-combo-treatment-could.aspx",
      "publishedDateTime": "2020-05-05T12:28:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Motley Fool",
        "domain": "fool.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/fool.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://g.foolcdn.com/editorial/images/497755/istock_000016851885_large_large.jpg",
          "width": 580,
          "height": 378,
          "title": "Regeneron Says Its COVID-19 Combo Treatment Could Be Ready for People This Fall",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-belgian-us-scientists-look-to-llama-in-search-for-covid-19-treatment.md",
      "title": "Belgian, U.S. scientists look to llama in search for COVID-19 treatment",
      "excerpt": "A llama called Winter could prove useful in the hunt for a treatment for COVID-19, according to U.S. and Belgian scientists who have identified a tiny particle that appears to block the new coronavirus.",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-health-coronavirus-antibodies-llamas-idUSKBN22H2QA",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKBN22H2QA",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN22H2QA",
      "publishedDateTime": "2020-05-05T12:26:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s3.reutersmedia.net/resources/r/?m=02&d=20200505&t=2&i=1517569393&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG441RK",
          "width": 362,
          "height": 545,
          "title": "Belgian, U.S. scientists look to llama in search for COVID-19 treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-poll-trumps-coronavirus-treatment-advice-more-harmful-than-helpful.md",
      "title": "Poll: Trump's coronavirus treatment advice more harmful than helpful",
      "excerpt": "President Donald Trump's advice on treating the coronavirus is more harmful than helpful a plurality of respondents said according to a new poll released Tuesday in the wake of the president's suggestion that Americans ingest or inject themselves with disinfectants.",
      "heat": 140,
      "tags": [
        "US"
      ],
      "type": "article",
      "webUrl": "https://www.politico.com/news/2020/05/05/poll-trump-coronavirus-treatment-advice-harmful-237400",
      "ampWebUrl": "https://www.politico.com/amp/news/2020/05/05/poll-trump-coronavirus-treatment-advice-harmful-237400",
      "cdnAmpWebUrl": "https://www-politico-com.cdn.ampproject.org/c/s/www.politico.com/amp/news/2020/05/05/poll-trump-coronavirus-treatment-advice-harmful-237400",
      "publishedDateTime": "2020-05-05T11:03:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Politico",
        "domain": "politico.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static.politico.com/22/df/e44543b743f597981943e4f0282b/20200505-trump-ap-773.jpg",
          "width": 1160,
          "height": 773,
          "title": "Poll: Trump's coronavirus treatment advice more harmful than helpful",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Political Impact",
        "Coronavirus in US"
      ]
    },
    {
      "path": "_news/2020-05-05-developing-an-effective-coronavirus-treatment-could-be-the-key-to-fighting-the-disease-experts-say.md",
      "title": "Developing an effective coronavirus treatment could be the key to fighting the disease, experts say",
      "excerpt": "While aggressive testing to contain the spread of Covid-19 remains a top priority, scientists and researchers believe that an effective treatment can be a valuable asset and a turning point in the fight against the pandemic.",
      "heat": 106,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/05/05/why-a-coronavirus-treatment-could-be-more-beneficial-than-a-vaccine.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/05/05/why-a-coronavirus-treatment-could-be-more-beneficial-than-a-vaccine.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/05/05/why-a-coronavirus-treatment-could-be-more-beneficial-than-a-vaccine.html",
      "publishedDateTime": "2020-05-05T10:24:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/106454435-1584733666814gettyimages-1204322480.jpeg?v=1586876065",
          "width": 6202,
          "height": 4135,
          "title": "Developing an effective coronavirus treatment could be the key to fighting the disease, experts say",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-midlands-hospitals-trying-front-runner-covid-19-drug-in-the-race-to-find-treatment.md",
      "title": "Midlands hospitals trying ‘front-runner’ COVID-19 drug in the race to find treatment",
      "excerpt": "Remdesivir showed some promising results during initial trials, and the FDA gave it emergency approval last week to be used in treating severe COVID-19 patients. These hospitals are seeing how well it works.",
      "heat": 103,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.thestate.com/news/coronavirus/article242492651.html",
      "ampWebUrl": "https://amp.thestate.com/news/coronavirus/article242492651.html",
      "cdnAmpWebUrl": "https://amp-thestate-com.cdn.ampproject.org/c/s/amp.thestate.com/news/coronavirus/article242492651.html",
      "publishedDateTime": "2020-05-05T08:25:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The State",
        "domain": "thestate.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/5615998031001/fef03f98-cc4e-4296-b326-56f0444c02b3/2eaa4e6f-1fca-476c-8518-438cc04155b3/1280x720/match/image.jpg",
          "width": 1280,
          "height": 720,
          "title": "Midlands hospitals trying ‘front-runner’ COVID-19 drug in the race to find treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-finding-a-coronavirus-cure-5-companies-making-moves.md",
      "title": "Finding a Coronavirus Cure: 5 Companies Making Moves",
      "excerpt": "Coronavirus and COVID-19 are probably the most searched words in 2020. We've watched the virus outbreak bring the world's health, economy, and markets to a damaging halt. Now as the \"curve\" begins to flatten,",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.fool.com/investing/2020/05/05/finding-a-coronavirus-cure-5-companies-making-move.aspx",
      "ampWebUrl": "https://www.fool.com/amp/investing/2020/05/05/finding-a-coronavirus-cure-5-companies-making-move.aspx",
      "cdnAmpWebUrl": "https://www-fool-com.cdn.ampproject.org/c/s/www.fool.com/amp/investing/2020/05/05/finding-a-coronavirus-cure-5-companies-making-move.aspx",
      "publishedDateTime": "2020-05-05T07:36:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Motley Fool",
        "domain": "fool.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/fool.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://g.foolcdn.com/editorial/images/497755/istock_000016851885_large_large.jpg",
          "width": 580,
          "height": 378,
          "title": "Finding a Coronavirus Cure: 5 Companies Making Moves",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-pfizer-begins-human-trials-of-possible-coronavirus-vaccine.md",
      "title": "Pfizer Begins Human Trials of Possible Coronavirus Vaccine",
      "excerpt": "The drug company, along with a German partner, is running tests in healthy volunteers. It’s one of several companies on an accelerated timetable to try to find a safe, effective vaccine.",
      "heat": 125,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nytimes.com/2020/05/05/health/pfizer-vaccine-coronavirus.html",
      "ampWebUrl": "https://www.nytimes.com/2020/05/05/health/pfizer-vaccine-coronavirus.amp.html",
      "cdnAmpWebUrl": "https://www-nytimes-com.cdn.ampproject.org/c/s/www.nytimes.com/2020/05/05/health/pfizer-vaccine-coronavirus.amp.html",
      "publishedDateTime": "2020-05-05T03:55:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "New York Times",
        "domain": "nytimes.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/nytimes.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static01.nyt.com/images/2020/05/05/science/05virus-pfizer/05virus-pfizer-facebookJumbo.jpg",
          "width": 1050,
          "height": 550,
          "title": "Pfizer Begins Human Trials of Possible Coronavirus Vaccine",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-coronavirus-treatment-ketamine-and-naltrexone-being-tested-as-covid-19-drugs.md",
      "title": "Coronavirus Treatment: Ketamine And Naltrexone Being Tested As COVID-19 Drugs",
      "excerpt": "The study is called “SINK COVID-19” and will be conducted at the Beaumont Hospital in Royal Oak, Oakland County.",
      "heat": 117,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.ibtimes.com/coronavirus-treatment-ketamine-naltrexone-being-tested-covid-19-drugs-2970324",
      "ampWebUrl": "https://www.ibtimes.com/coronavirus-treatment-ketamine-naltrexone-being-tested-covid-19-drugs-2970324?amp=1",
      "cdnAmpWebUrl": "https://www-ibtimes-com.cdn.ampproject.org/c/s/www.ibtimes.com/coronavirus-treatment-ketamine-naltrexone-being-tested-covid-19-drugs-2970324?amp=1",
      "publishedDateTime": "2020-05-05T03:01:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "International Business Times",
        "domain": "ibtimes.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s1.ibtimes.com/sites/www.ibtimes.com/files/styles/full/public/2020/05/03/map-of-europe-showing-covid-19-deaths-per.jpg",
          "width": 756,
          "height": 768,
          "title": "Coronavirus Treatment: Ketamine And Naltrexone Being Tested As COVID-19 Drugs",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-05-stem-cell-treatment-for-coronavirus-symptoms-being-trialed-in-the-uae.md",
      "title": "Stem cell treatment for coronavirus symptoms being trialed in the UAE",
      "excerpt": "Kaabi of the Sheikh Khalifa Medical City discusses a stem cell treatment currently being tested for its efficacy in alleviating coronavirus symptoms, and the easing of the lockdown in the UAE.",
      "heat": 100,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cnbc.com/video/2020/05/05/stem-cell-treatment-for-coronavirus-symptoms-being-trialed-in-the-uae.html",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-05-05T02:37:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/106519960-15886601293ED6-CCA-050520-AFatimaalKaabi.jpg?v=1588660128",
          "width": 1920,
          "height": 1080,
          "title": "Stem cell treatment for coronavirus symptoms being trialed in the UAE",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-04-us-emergency-approval-broadens-use-of-gileads-covid-19-drug-remdesivir.md",
      "title": "U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir",
      "excerpt": "Gilead Science Inc’s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Admini",
      "heat": 104,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/health-coronavirus-usa-fda/us-emergency-approval-broadens-use-of-gileads-covid-19-drug-remdesivir-idUSL1N2CM0ZH",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSL1N2CM0ZH",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSL1N2CM0ZH",
      "publishedDateTime": "2020-05-04T13:43:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s4.reutersmedia.net/resources_v3/images/rcom-default.png",
          "width": 1200,
          "height": 630,
          "title": "U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-04-stem-cell-treatment-in-the-uae-sees-favorable-outcomes-for-coronavirus-patients.md",
      "title": "Stem cell treatment in the UAE sees 'favorable' outcomes for coronavirus patients",
      "excerpt": "A new treatment that helps to relieve coronavirus symptoms could be brought to market in three months’ time if further trials go well, according to a researcher involved in the project. “It’s very early to say at this stage,",
      "heat": 115,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/05/04/coronavirus-uae-stem-cell-treatment-sees-favorable-outcome.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/05/04/coronavirus-uae-stem-cell-treatment-sees-favorable-outcome.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/05/04/coronavirus-uae-stem-cell-treatment-sees-favorable-outcome.html",
      "publishedDateTime": "2020-05-04T11:35:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/106518107-1588588233485gettyimages-1222602309.jpeg?v=1588588284",
          "width": 5367,
          "height": 3578,
          "title": "Stem cell treatment in the UAE sees 'favorable' outcomes for coronavirus patients",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-04-who-says-it-will-engage-us-to-make-remdesivir-coronavirus-treatment-more-widely-available.md",
      "title": "WHO says it will engage US to make remdesivir coronavirus treatment more widely available",
      "excerpt": "WHO welcomes the recent data from a U.S. government-run clinical trial showing the drug appeared to be effective in reducing recovery times for Covid-19 patients, one official says.",
      "heat": 111,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/05/04/remdesivir-coronavirus-treatment-who-to-talk-with-us-on-making-drug-available.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/05/04/remdesivir-coronavirus-treatment-who-to-talk-with-us-on-making-drug-available.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/05/04/remdesivir-coronavirus-treatment-who-to-talk-with-us-on-making-drug-available.html",
      "publishedDateTime": "2020-05-04T10:44:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/106460708-1585165953635gettyimages-1207933754.jpeg?v=1587146153",
          "width": 4000,
          "height": 2667,
          "title": "WHO says it will engage US to make remdesivir coronavirus treatment more widely available",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-04-experts-weigh-in-on-how-much-a-dose-of-a-successful-coronavirus-vaccine-could-cost.md",
      "title": "Experts weigh in on how much a dose of a successful coronavirus vaccine could cost",
      "excerpt": "Pharmaceutical companies say they'll keep the price of a coronavirus vaccine low, but inflated price tags have become the industry norm.",
      "heat": 109,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.businessinsider.com/how-much-will-coronavirus-vaccine-cost-2020-5",
      "ampWebUrl": "https://www.businessinsider.com/how-much-will-coronavirus-vaccine-cost-2020-5?amp",
      "cdnAmpWebUrl": "https://www-businessinsider-com.cdn.ampproject.org/c/s/www.businessinsider.com/how-much-will-coronavirus-vaccine-cost-2020-5?amp",
      "publishedDateTime": "2020-05-04T10:25:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Business Insider",
        "domain": "businessinsider.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/businessinsider.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://i.insider.com/5eb0308248d92c7af62784c5?width=1200&format=jpeg",
          "width": 1200,
          "height": 600,
          "title": "Experts weigh in on how much a dose of a successful coronavirus vaccine could cost",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Political Impact"
      ]
    },
    {
      "path": "_news/2020-05-04-covid-19-vaccine-hunt-heats-up-globally-still-no-guarantee.md",
      "title": "COVID-19 vaccine hunt heats up globally, still no guarantee",
      "excerpt": "Hundreds of people are rolling up their sleeves in countries across the world to be injected with experimental vaccines that might stop COVID-19, spurring hope () -- maybe unrealistic () -- that an end",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.abqjournal.com/1450933/covid-19-vaccine-hunt-heats-up-globally-still-no-guarantee.html",
      "ampWebUrl": "https://www.abqjournal.com/1450933/covid-19-vaccine-hunt-heats-up-globally-still-no-guarantee.html/amp",
      "cdnAmpWebUrl": "https://www-abqjournal-com.cdn.ampproject.org/c/s/www.abqjournal.com/1450933/covid-19-vaccine-hunt-heats-up-globally-still-no-guarantee.html/amp",
      "publishedDateTime": "2020-05-04T10:11:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Albuquerque Journal",
        "domain": "abqjournal.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://d3el53au0d7w62.cloudfront.net/wp-content/uploads/2020/05/04/BC-US-MED-Virus-Outbreak-Vaccine-Race-IMG-630x354.jpg",
          "width": 630,
          "height": 354,
          "title": "COVID-19 vaccine hunt heats up globally, still no guarantee",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-04-five-year-old-florida-girl-gets-huge-parade-to-mark-last-cancer-treatment-after-coronavirus-cancels-party.md",
      "title": "Five-Year-Old Florida Girl Gets Huge Parade to Mark Last Cancer Treatment After Coronavirus Cancels Party",
      "excerpt": "Around 150 cars took part in a parade to celebrate five-year-old Selah Grace Feely's final chemotherapy treatment.",
      "heat": 113,
      "tags": [
        "US-FL"
      ],
      "type": "article",
      "webUrl": "https://www.newsweek.com/five-year-old-florida-girl-gets-huge-parade-mark-last-cancer-treatment-after-coronavirus-cancels-1501800",
      "ampWebUrl": "https://www.newsweek.com/five-year-old-florida-girl-gets-huge-parade-mark-last-cancer-treatment-after-coronavirus-cancels-1501800?amp=1",
      "cdnAmpWebUrl": "https://www-newsweek-com.cdn.ampproject.org/c/s/www.newsweek.com/five-year-old-florida-girl-gets-huge-parade-mark-last-cancer-treatment-after-coronavirus-cancels-1501800?amp=1",
      "publishedDateTime": "2020-05-04T08:03:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Newsweek",
        "domain": "newsweek.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/newsweek.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://d.newsweek.com/en/full/1587103/stock-photo-car-parade.jpg",
          "width": 2121,
          "height": 1414,
          "title": "Five-Year-Old Florida Girl Gets Huge Parade to Mark Last Cancer Treatment After Coronavirus Cancels Party",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus in US",
        "Coronavirus",
        "Treatment"
      ]
    }
  ],
  "nextPage": 3
}